|
Baseline characteristics |
||||||
| PATIENT |
TRANSMISSION |
GENDER |
Age(years+months) |
CATEGORY(CDC) |
TANNER * |
LIPODYSTROPHY |
|
|
||||||
| 1 |
UNKNOWN |
GIRL |
13 Y 7 M |
A1 |
III to V |
no |
| 2 |
VERTICAL |
BOY |
9 Y 10 M |
A3 |
I-I |
no |
| 3 |
VERTICAL |
BOY |
8 Y 3 M |
A1 |
I-I |
no |
| 4 |
VERTICAL |
GIRL |
9 Y 2 M |
C3 |
I-I |
no |
| 5 |
VERTICAL |
BOY |
10 Y |
C3 |
I-I |
no |
| 6 |
VERTICAL |
BOY |
14 Y 7 M |
B2 |
II-III |
lipoatrohy |
| 7 |
VERTICAL |
BOY |
8 Y 2 M |
B2 |
II-III |
lipohypertrophy |
| MEDIAN |
133(99,177) |
|||||
|
* Puberty stage. Tanner JM. Grow and adolescence (2aedition) Oxford. Blackwell Scientific publication. 1962 | ||||||
Gonzalez-Tome et al. BMC Infectious Diseases 2008 8:144 doi:10.1186/1471-2334-8-144 |
||||||